C Munzer

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification

O. Delattre, J. Klijanienko, H. Brisse, 2007, British Journal of Cancer.

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)

O. Delattre, G. Tonini, P. Ambros, 2011, British Journal of Cancer.

Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study.

A Garaventa, S Parodi, R Haupt, 2013, European journal of cancer.